Concepedia

Sylvia Salter

SS

3

Publications

178

Citations

3

H-Index

2004

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

Loughborough University

Sylvia Salter is an author at AstraZeneca (United Kingdom) specializing in drug discovery, pharmacotherapy, and medicine.

ORCID

Top concepts

Publications per year

2004–2006

3

Publications

3

Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors

Andrew Baxter, Steve Brough, Anne Cooper et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 90 citations

, , +11

A truncated form of CK<i>β</i>8‐1 is a potent agonist for human formyl peptide‐receptor‐like 1 receptor

Aram Elagöz, Duncan J. Henderson, Poda Suresh Babu et al. · British Journal of Pharmacology · 2004 · 46 citations · Full text

Discovery of potent CRTh2 (DP2) receptor antagonists

Timothy N. Birkinshaw, Simon J. Teague, Claire L. Beech et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 42 citations · Full text

, , +6

Rows per page

1–3 of 3